Precio de cierre
Otros sitios de cotización
|
||
- GBX | - |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Research Collaboration - AstraZeneca
53,9
%
| 6 | 29,0 % | 17 | 53,9 % | +171,74 % |
Research Collaboration - Mallinckrodt Plc
41,6
%
| 14 | 66,6 % | 13 | 41,6 % | -8,73 % |
Research Collaboration - Other
2,3
%
| 0 | 1,1 % | 1 | 2,3 % | +218,10 % |
Royalties
2,2
%
| 1 | 3,3 % | 1 | 2,2 % | -0,66 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
97,8
%
| 21 | 96,7 % | 31 | 97,8 % | +47,92 % |
Germany
2,2
%
| 1 | 3,3 % | 1 | 2,2 % | -0,66 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 06/01/21 |
Director of Finance/CFO | 52 | 01/04/21 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/17 | |
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29/07/19 |
Gem Hopkins
IRC | Investor Relations Contact | - | 01/08/20 |
J.P. Gabriel
PRN | Corporate Officer/Principal | - | 06/02/23 |
Human Resources Officer | - | 01/11/17 | |
Eric Floyd
LAW | General Counsel | 61 | 01/07/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29/07/19 |
David Lemus
BRD | Director/Board Member | 61 | 21/06/18 |
Iain Ross
CHM | Chairman | 71 | 02/07/04 |
Craig Tooman
CEO | Chief Executive Officer | 58 | 06/01/21 |
Director/Board Member | 44 | 25/04/19 | |
Michael Davidson
BRD | Director/Board Member | 67 | 06/01/21 |
Información de la empresa
Silence Therapeutics Plc
72 Hammersmith Road
W14 8TH, London
+44 20 3457 6900
http://www.silence-therapeutics.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Miscellaneous Commercial Services
|
Sector
Ventas por actividad
Ventas por región
- Bolsa de valores
- Acciones
- Acción SLN
- Acción
- Empresa Silence Therapeutics plc